Journals / Epilepsi / 2016 / Cilt: 22 - Sayı: 2

A Case of Delusion During Epilepsy Treatment Following Lamotrigine Add-On

Epilepsi Tedavisi Sırasında Lamotrijin Ekleme ile Ortaya Çıkan Sanrılar

Journal
Epilepsi
Pages
72–74
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Psychotic episodes resulting from rapid increase in LTG serum level hasbeen documented.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Epilepsy may appear in comorbidity with other neurological disorders.
📊
Key Findings & Data:Described in the present report is the case of a 23-year-old male patient with an 8-year history of partialepilepsy and a familial history of bipolarity.
💡
Conclusion & Impact:Psychotic episodes resulting from rapid increase in LTG serum level hasbeen documented.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Epilepsy may appear in comorbidity with other neurological disorders. Nevertheless, epileptic seizures and antiepileptic drugs may be responsible for the development of cognitive dysfunctions and mental disorders. Some epileptic seizures may develop with mood disorders,including depressive symptoms. Described in the present report is the case of a 23-year-old male patient with an 8-year history of partialepilepsy and a familial history of bipolarity. He had been treated for partial-onset seizures with carbamazepine and oxcarbazepine, andlamotrigine (LTG) was gradually added to treat depressive symptoms, reaching a twice-daily dosage of 100 mg. The patient developed paranoid delusions involving his neighbors, delusions which subsided after dosage was decreased to 150 mg/day. Seizure control was good, andpsychiatric symptoms resolved when the dosage was decreased. Psychotic episodes resulting from rapid increase in LTG serum level hasbeen documented.

Özet

Epilepsi ruhsal bozukluklarla birlikte görülebilir, bununla beraber epileptik ataklar ve antiepileptik ilaçlar epilepsisi olan hastalarda bilişsel ve ruhsal bozuklukların gelişiminde sorumlu tutulabilmektadır. Bazı epileptik ataklar, depresif semptomlar dahil duygudurum bozukluklarına eşlik edebilir. Yirmi üç yaşında, sekiz yıllık parisyel başlangıçlı epilepsi öyküsü olup karbamazepin ve okskarbazepin alırken kontrolden çıkan ve kardeşinde bipolar bozukluk olan 23 yaşındaki erkek hastaya depresif semptomlarının da olması nedeniyle lamotrijin (LTG) eklenmiş ve kademeli olarak günde 2x100 mg dozuna çıkartılmış, 200 mg/g dozunda, hastada komşuları tarafından takip edildiği ve dinlendiği yönünde paranoid sanrılar çıkmış, LTG’nin 150 mg/g dozuna düşürüldüğümde psikiyatrik bulgu ve belirtiler kaybolmuştur. Lamotrijinin azaltılmasından sonraki bir hafta içinde hezeyanların hafiflemesi ve giderek kaybolması nedeniyle psikiyatrik bir tedavi planlanmadı. Literatürde bildirilen benzer olgular gibi olan bu olguda da genellikle LTG dozunun hızlı artırılması sonucunda psikotik ataklara ve pikiyatrik sunumların başlamasına neden olabileceğini ve ayrca birlikte kullanılan tedavilerin LTG serum seviyelerinde artışa neden olabileceğini düşündürmektedir.

🔖

Cite This Article

ÖZEN, M. E., KALENDEROĞLU, A., ÇELİK, M. (2022). A Case of Delusion During Epilepsy Treatment Following Lamotrigine Add-On. Epilepsi, Cilt: 22 - Sayı: 2, 72–74. https://ajindex.com/articles/501678

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW, et al. The SANAD study of effectiveness of carbamazepine, gabapentin, lamotrigine, oxcarbazepine, or topiramate for treatment of partial epilepsy: an unblinded randomised controlled trial. Lancet 2007;369(9566):1000–15.
  2. Bowden CL, Calabrese JR, Sachs G, Yatham LN, Asghar SA, Hompland M, et al. A placebo-controlled 18-month trial of lamotrig ine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 2003;60(4):392–400. American Psychiatric Association. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry 2002;159(4 Suppl):1–50.
  3. Calabrese JR, Bowden CL, Sachs G, Yatham LN, Behnke K, Mehtonen OP, et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry 2003;64(9):1013–24.
  4. Desarkar P, Sinha VK. Lamotrigine-induced severe manic switch. Aust N Z J Psychiatry 2006;40(8):718. Savas HA, Selek S, Bulbul F, Kaya MC, Savas E. Successful treatment with lamotrigine in bipolar depression: a study from Turkey. Aust N Z J Psychiatry 2006;40(5):498–500.
  5. Selek S, Savas HA. Lamotrigine-induced manic switches have already been reported. Aust N Z J Psychiatry 2007;41(2):195. Margolese HC, Beauclair L, Szkrumelak N, Chouinard G. Hypomania induced by adjunctive lamotrigine. Am J Psychiatry 2003;160(1):183–4.
  6. Matsuo F, Bergen D, Faught E, Messenheimer JA, Dren AT, Rudd GD, et al. Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. U.S. Lamotrigine Protocol 0.5 Clinical Trial Group. Neurology 1993;43(11):2284– 91. Brandt C, Fueratsch N, Boehme V, Kramme C, Pieridou M, Villagran A, et al. Development of psychosis in patients with epilepsy treated with lamotrigine: report of six cases and review of the literature. Epilepsy Behav 2007;11(1):133–9.
  7. Martin M, Muñoz-Blanco JL, Lopez-Ariztegui N. Acute psychosis induced by lamotrigine. Epilepsia 1995;36:118 Polselli GM, Pennisi EM, Figà Talamanca L, Roberti R, Garelli FF, Bandinelli PL. Psychotic disorder after lamotrigine. Ital J Neurol Sci 1998;19(2):124–5.